These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 14390079)

  • 1. [Stilbamidine therapy of plasmacytoma].
    TOMEK S
    Wien Klin Wochenschr; 1951 Nov; 63(47):892-5. PubMed ID: 14901804
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in serum proteins in stilbamidine therapy of plastocytoma].
    RUDAS I; SCHULLER A
    Orv Hetil; 1957 Mar; 98(9):207-9. PubMed ID: 13431275
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic attempts with a stilbenes derivative in plasmocytoma; report of three cases].
    LOOS D
    Z Gesamte Inn Med; 1955 Jan; 10(2):70-9. PubMed ID: 14374775
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood protein changes in a case of plasmocytoma during stilbamidine therapy].
    WENZEL E
    Z Gesamte Inn Med; 1952 Feb; 7(3):141-4. PubMed ID: 14932047
    [No Abstract]   [Full Text] [Related]  

  • 5. Diamidines in myelomatosis.
    BICHEL J
    Acta radiol; 1952 Jan; 37(1):65-73. PubMed ID: 14902604
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of stilbamidine on multiple myeloma].
    FOIT R; SIEBEROVA-KLIMOVA R
    Cas Lek Cesk; 1952 Jan; 91(2):40-4. PubMed ID: 14390079
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of allogeneic stem cell transplantation in multiple myeloma.
    Thomson KJ; Peggs KS
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):455-64. PubMed ID: 16001953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the phosphatidylinositol 3-kinase pathway in multiple myeloma.
    Younes H; Leleu X; Hatjiharissi E; Moreau AS; Hideshima T; Richardson P; Anderson KC; Ghobrial IM
    Clin Cancer Res; 2007 Jul; 13(13):3771-5. PubMed ID: 17606706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches in the treatment of multiple myeloma.
    Abedi M; Elfenbein GJ
    Med Health R I; 2003 Aug; 86(8):231-5. PubMed ID: 14582216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update: health economics of managing multiple myeloma.
    Moeremans K; Annemans L
    Eur J Cancer; 2006 Jul; 42(11):1684-91. PubMed ID: 16781867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic haematopoietic cell transplantation for multiple myeloma: reducing transplant-related mortality while harnessing the graft-versus-myeloma effect.
    Zeiser R; Finke J
    Eur J Cancer; 2006 Jul; 42(11):1601-11. PubMed ID: 16759847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guidelines for the diagnosis and management of multiple myeloma by the Japan Myeloma Study Group].
    Shimizu K;
    Rinsho Ketsueki; 2005 Jun; 46(6):424-32. PubMed ID: 16447724
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.